| Joel M Topf, MD | |
|
18001 E 10 Mile Rd, Suite 1, Roseville, MI 48066-3803 | |
| (586) 218-5800 | |
| (586) 218-5808 |
| Full Name | Joel M Topf |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 29 Years |
| Location | 18001 E 10 Mile Rd, Roseville, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972505519 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | JT055706 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Macomb Kidney Center Of Davita | Warren, MI | Dialysis facility |
| Grosse Pointe Dialysis Of Davita | Detroit, MI | Dialysis facility |
| Ascension St John Hospital | Detroit, MI | Hospital |
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Beaumont Hospital - Grosse Pointe | Grosse pointe, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Clair Specialty Physicians Pc | 6204733256 | 36 |
News Archive
Marcellus shale extraction and its potential negative effects on the environment is the subject of a recently published special issue in the Journal of Environmental Science and Health, Part A.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.
A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen.
Changes in the expression of genes may be the reason why people who abuse inhalants, such as spray paint or glue, quickly develop a tolerance, biologists at The University of Texas at Austin have discovered.
› Verified 7 days ago
| Entity Name | St Clair Specialty Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154361616 PECOS PAC ID: 6204733256 Enrollment ID: O20040310000808 |
News Archive
Marcellus shale extraction and its potential negative effects on the environment is the subject of a recently published special issue in the Journal of Environmental Science and Health, Part A.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.
A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen.
Changes in the expression of genes may be the reason why people who abuse inhalants, such as spray paint or glue, quickly develop a tolerance, biologists at The University of Texas at Austin have discovered.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel M Topf, MD 45640 Schoenherr Rd, Suite B, Shelby Township, MI 48315-6033 Ph: (586) 247-4300 | Joel M Topf, MD 18001 E 10 Mile Rd, Suite 1, Roseville, MI 48066-3803 Ph: (586) 218-5800 |
News Archive
Marcellus shale extraction and its potential negative effects on the environment is the subject of a recently published special issue in the Journal of Environmental Science and Health, Part A.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.
A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen.
Changes in the expression of genes may be the reason why people who abuse inhalants, such as spray paint or glue, quickly develop a tolerance, biologists at The University of Texas at Austin have discovered.
› Verified 7 days ago
Robert Lewis Marchese, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 25810 Kelly Rd, Suite 3, Roseville, MI 48066 Phone: 586-777-9724 Fax: 586-777-9725 | |
Benjamin O Osowa, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18263 E 10 Mile Rd, Suite E, Roseville, MI 48066 Phone: 586-552-8696 Fax: 586-552-4404 | |
Dr. Majid Alzagoum, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066 Phone: 586-776-8877 Fax: 586-776-3092 | |
Dr. Wahed Ishaqsei, M.D. Nephrology Medicare: May Accept Medicare Assignments Practice Location: 18263 E 10 Mile Rd, Suite D, Roseville, MI 48066 Phone: 586-778-4950 Fax: 586-778-4952 | |
Dr. Mohamad K. Ajjour, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066 Phone: 586-776-8877 Fax: 586-776-3092 | |
Dr. Ameer Abdulrazzak, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18001 E 10 Mile, Suite 1, Roseville, MI 48066 Phone: 586-218-5800 Fax: 586-218-5808 | |
Dr. Madjid Mesgarzadeh, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 25910 Kelly Rd, Suite B, Roseville, MI 48066 Phone: 586-772-3366 Fax: 586-772-3355 |